A new vaccine tested on 18 women with triple-negative breast cancer triggered a strong immune response, according to researchers who say 16 participants remain cancer-free three years after treatment.
Health News is provided as a service to Twain Harte Pharmacy site users by HealthDay. Twain Harte Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.